⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9880642 | 0.81 | — | — | |
| SCHEMBL16235382 | 0.81 | — | — | |
| SCHEMBL16248187 | 0.75 | GABRA1 (0.45) | — | |
| SCHEMBL4359807 | 0.72 | GPR35 (0.52) | — | |
| SCHEMBL337576 | 0.72 | — | — | |
| SCHEMBL28053348 | 0.71 | IDO1 (0.32) | — | |
| SCHEMBL15108814 | 0.69 | — | — | |
| SCHEMBL4659931 | 0.69 | — | — | |
| SCHEMBL18189390 | 0.69 | — | — | |
| SCHEMBL3259977 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12084457-B2 | Methods for the preparation of 1,3-benzodioxole heterocyclic compounds | UNION therapeutics A/S (DK) | 2024-09-10 | — | — | US | claimed |
| CN-118344381-A | Process for preparing 1, 3-benzodioxole heterocyclic compounds | 联合疗法公司 | 2024-07-16 | — | — | CN | claimed |
| CN-114105865-A | Synthesis process of 3,4, 5-trichloropyridine | 江苏宝众宝达药业股份有限公司 | 2022-03-01 | — | — | CN | claimed |
| EP-3642210-B1 | METHODS FOR THE PREPARATION OF 1,3-BENZODIOXOLE HETEROCYCLIC COMPOUNDS | UNION THERAPEUTICS AS (DK) | 2024-11-13 | — | — | EP | disclosed |
| US-12084457-B2 | Methods for the preparation of 1,3-benzodioxole heterocyclic compounds | UNION therapeutics A/S (DK) | 2024-09-10 | — | — | US | disclosed |
| CN-118344381-A | Process for preparing 1, 3-benzodioxole heterocyclic compounds | 联合疗法公司 | 2024-07-16 | — | — | CN | disclosed |
| CN-110741005-B | Process for preparing 1, 3-benzodioxole heterocyclic compounds | 联合疗法公司 | 2024-04-12 | — | — | CN | disclosed |
| US-20220162227-A1 | METHODS FOR THE PREPARATION OF 1,3-BENZODIOXOLE HETEROCYCLIC COMPOUNDS | UNION therapeutics A/S (DK) | 2022-05-26 | — | — | US | disclosed |
| CN-114105865-A | Synthesis process of 3,4, 5-trichloropyridine | 江苏宝众宝达药业股份有限公司 | 2022-03-01 | — | — | CN | disclosed |
| CN-114105865-A | Synthesis process of 3,4, 5-trichloropyridine | 江苏宝众宝达药业股份有限公司 | 2022-03-01 | — | — | CN | disclosed |
| US-11220514-B2 | Methods for the preparation of 1,3-benzodioxole heterocyclic compounds | UNION therapeutics A/S (DK) | 2022-01-11 | — | — | US | disclosed |
| EP-1824843-A2 | INHIBITORS OF PROTEIN KINASES | Locus Pharmaceuticals, Inc. (US) | 2007-08-29 | — | — | EP | disclosed |
| US-20070185098-A1 | Inhibitors of protein kinases | LOCUS PHARMACEUTICALS, INC. (US) | 2007-08-09 | — | — | US | disclosed |
| WO-2007081690-A2 | INHIBITORS OF PROTEIN KINASES | LOCUS PHARMACEUTICALS, INC. (US) | 2007-07-19 | — | — | WO | disclosed |
| WO-2006062984-A2 | INHIBITORS OF PROTEIN KINASES | LOCUS PHARMACEUTICALS, INC. (US) | 2006-06-15 | — | — | WO | disclosed |
| EP-0676397-B1 | Oxopyridinylquinoxaline derivatives | SHIONOGI & CO (JP) | 1999-10-20 | — | — | EP | disclosed |
| US-5677305-A | NERVOUS SYSTEM DISORDERS | SHIONOGI & CO., LTD. (JP) | 1997-10-14 | — | — | US | disclosed |
| EP-0676397-A1 | Oxopyridinylquinoxaline derivatives | SHIONOGI & CO., LTD. (JP) | 1995-10-11 | — | — | EP | disclosed |
| EP-0427549-A1 | Heterocyclic oxy-phenoxyacetic acid derivatives and their use as herbicides | SHIONOGI SEIYAKU KABUSHIKI KAISHA (JP) | 1991-05-15 | — | — | EP | disclosed |
| US-4173638-A | N-Benzoyl-N'-pyridyloxy phenyl urea and insecticidal compositions thereof | ISHIHARA SANGYO KAISHA LTD. (JP) | 1979-11-06 | — | — | US | disclosed |